Volume 31, Issue 4 236082 pp. 199-203
Article
Open Access

HLA and Bronchopulmonary Dysplasia Susceptibility: A Pilot Study

Gustavo Rocha

Corresponding Author

Gustavo Rocha

Departament of Pediatrics Division of Neonatology Hospital de São João Porto, Portugal

Faculty of Medicine of Porto University Porto, Portugal

Search for more papers by this author
Elisa Proença

Elisa Proença

Division of Neonatology Maternity Júlio Dinis Porto Hospital Centre Porto, Portugal

Search for more papers by this author
Augusta Areias

Augusta Areias

Division of Neonatology Maternity Júlio Dinis Porto Hospital Centre Porto, Portugal

Search for more papers by this author
Fátima Freitas

Fátima Freitas

Centre of Histocompatibility of Porto Porto, Portugal

Search for more papers by this author
Bruno Lima

Bruno Lima

Centre of Histocompatibility of Porto Porto, Portugal

Search for more papers by this author
Teresa Rodrigues

Teresa Rodrigues

Department of Hygiene and Epidemiology Porto, Portugal

Faculty of Medicine of Porto University Porto, Portugal

Search for more papers by this author
Helena Alves

Helena Alves

Centre of Histocompatibility of Porto Porto, Portugal

Search for more papers by this author
Hercília Guimarães

Hercília Guimarães

Departament of Pediatrics Division of Neonatology Hospital de São João Porto, Portugal

Faculty of Medicine of Porto University Porto, Portugal

Search for more papers by this author
First published: 27 May 2013
Citations: 2

Abstract

There is little data on the association between Human Leucocyte Antigen (HLA) alleles and Bronchopulmonary Dysplasia (BPD) of the preterm newborn. Our aim was to assess associations between HLA alleles and BPD susceptibility. We studied 156 preterm neonates (82 M/74 F) < 32 weeks gestational age, alive at 36 weeks gestational age. Detailed clinical data were collected. HLA typing was performed by PCR-SSO. HLA allele frequencies where determined by direct counting for BPD and no-BPD groups. Comparison between BPD and no BPD groups was performed using t-test, χ2 test or Fisher exact test and logistic regression as appropriate. Relative risks (RR) and their 95% confidence intervals (95% CI) were also calculated as association measures. We diagnosed 56 (35.9%) neonates with mild BPD and 27 (17%) with moderate/severe BPD. We found a significant association between HLA-DRB1*01 and mild BPD (OR=3.48[1.23–10.2]). The alleles HLA-A*24, -A*68, -B*51,-Cw*07, -Cw*14, -Cw*15 and -DRB1*01 presented a significant association with moderate/severe BPD. When adjusted to gestational age and birth weight HLA-A*68 (OR=5.41[1.46; 20.05]), -B*51 (OR=3.09[1.11; 8.63]) and -Cw*14 (OR=4.94[1.15; 21.25]) were significantly associated with moderate/severe BPD. Conclusion – Our findings suggest an association between HLA-A*68, -B*51 and -C*14 and BPD susceptibility, and that an autoimmune mechanism may be implicated in the pathogenesis of the disease.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.